Reason for request
Inclusion on the list of medicines refundable by National Health Insurance (boxes of 28 and 56) and approved for hospital use (boxes of 28, 49 and 56).
-
Clinical Benefit
Moderate |
The actual benefit of TREDAPTIVE in combination with statins is moderate in patients with hypercholesterolaemia who are not controlled by a statin alone and in whom lowering of TG and raising of HDL cholesterol is required. |
Clinical Added Value
no clinical added value |
TREDAPTIVE does not provide an improvement in actual benefit (IAB V) in the management of patients with mixed dyslipidaemia who are not controlled by statins alone |
English version
Contact Us
Évaluation des médicaments